High-Dose Melphalan Significantly Increases Mutational Burden in Multiple Myeloma Cells at Relapse: Results from a Randomized Study in Multiple Myeloma
Year: 2020
Type: article
Source: Blood
Authors: Mehmet K. Samur, Marco Roncador, Anil Aktas-Samur, Mariateresa Fulciniti, Abdul Hamid Bazarbachi, Raphael Szalat, Masood A. Shammas, Adam S Sperling, Paul G. Richardson, Florence Magrangeas, Stephane Minvielle, Anjan Thakurta, Aurore Perrot, Jill Corre, Philippe Moreau, Kenneth Anderson, Giovanni Parmigiani, Herve Avet-Loiseau, Nikhil C. Munshi
Institutions: Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Boston University, VA Boston Healthcare System, Université de Nantes, Nantes Université, Centre National de la Recherche Scientifique, Inserm, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Bristol-Myers Squibb (United States), Institut universitaire du cancer de Toulouse Oncopole, Centre Hospitalier Universitaire de Nantes
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3095991104